Ganga Pharmaceuticals Limited (BOM:539680)
India · Delayed Price · Currency is INR 12.50
+0.50 (4.17%)
At close: Sep 8, 2026
Ganga Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 0.95 | 1.02 | 0.79 | 0.47 | 0.39 | 0.38 |
Depreciation & Amortization | 0.59 | 0.56 | 0.47 | 0.49 | 0.56 | 0.55 |
Loss (Gain) From Sale of Investments | - | - | -1.88 | - | - | - |
Other Operating Activities | -1.61 | -1.59 | -0.78 | -0.59 | -1.14 | -0.69 |
Change in Accounts Receivable | -0.12 | -0.28 | 0.13 | -0.34 | 0.03 | -0.72 |
Change in Inventory | -0.04 | 0.17 | 0.59 | -0.59 | -0.33 | -0.17 |
Change in Accounts Payable | -0.36 | -1.6 | 1.78 | -4.81 | 0.55 | 0.85 |
Change in Other Net Operating Assets | -4.7 | -11.39 | -6.86 | -7.28 | -0.47 | -2.31 |
Operating Cash Flow | -5.29 | -13.11 | -5.77 | -12.64 | -0.4 | -2.11 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -0.28 | -0.37 | -0.99 | -0.22 | -0.15 | -0.15 |
Investment in Securities | 6.08 | 0.02 | 10.32 | -0.88 | 2.09 | -0.55 |
Other Investing Activities | 2.68 | 2.79 | 2.48 | 2.39 | 2.98 | 2.59 |
Investing Cash Flow | 8.48 | 2.44 | 11.81 | 1.3 | 4.92 | 1.89 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | - | - | - | - | 2.18 |
Long-Term Debt Repaid | - | -1.34 | -1.63 | -2.4 | -2.57 | - |
Net Debt Issued (Repaid) | -1.6 | -1.34 | -1.63 | -2.4 | -2.57 | 2.18 |
Issuance of Common Stock | - | 10.8 | - | 10.85 | - | - |
Other Financing Activities | -1.12 | -1.23 | -1.69 | 2.9 | -1.87 | -1.9 |
Financing Cash Flow | -3.21 | 8.23 | -3.32 | 11.35 | -4.44 | 0.27 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | -0 | 0 | - |
Net Cash Flow | -0.03 | -2.44 | 2.73 | 0.01 | 0.09 | 0.06 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -5.57 | -13.48 | -6.76 | -12.86 | -0.55 | -2.25 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -19.74% | -47.65% | -25.63% | -47.02% | -2.11% | -9.06% |
Free Cash Flow Per Share | -2.61 | -2.28 | -1.02 | -1.95 | -0.14 | -0.56 |
Levered Free Cash Flow | -4.43 | -11.81 | -9.22 | -11.54 | -2.85 | -3.05 |
Unlevered Free Cash Flow | -3.73 | -11.04 | -8.16 | -10.41 | -1.68 | -1.86 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 0.57 | 1.23 | 1.69 | 1.81 | 1.87 | 1.9 |
Cash Income Tax Paid | 0.3 | 0.3 | 0.15 | 0.17 | 0.16 | 0.14 |
Change in Working Capital | -5.22 | -13.1 | -4.36 | -13.01 | -0.22 | -2.35 |